Electroconvulsive therapy (ECT) for dementia with Lewy bodies

Medical Hypotheses

Volumn 75, Issue 2, 2010, Pages 139-140

  Tuna Burgut, F ^a   Kellner, Charles H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR; LEVODOPA; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; COGNITION; DELUSION; DEPRESSION; DIFFUSE LEWY BODY DISEASE; EDITORIAL; ELECTROCONVULSIVE THERAPY; HALLUCINATION; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; PARKINSONISM; PSYCHOSIS; SIDE EFFECT; VISUAL HALLUCINATION; COMPARATIVE STUDY; DEMENTIA; LEWY BODY; METABOLISM; PROCEDURES;

DEMENTIA; ELECTROCONVULSIVE THERAPY; HUMANS; LEWY BODIES;

EID: 77954312763     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.05.001     Document Type: Editorial

References (22)

1. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005, 65(12):1863-1872.
2. Wesnes K.A., McKeith I.G., Ferrara R., et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomized placebo-controlled international study using the cognitive drug research computerized assessment system. Dement Geriatr Cogn Disord 2002, 13(3):183-192.
3. Molloy S., McKeith I.G., O'Brien J.T., Burn D.J. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005, 76(9):1200-1203.
4. Fernandez H.H., Wu C.K., Ott B.R. Pharmacotherapy of dementia with Lewy bodies. Expert Opin Pharmacother 2003, 4(11):2027-2037.
5. McKeith I.G., Perry R.H., Fairbairn A.F., et al. Operational criteria for senile dementia of Lewy body type. Psychol Med 1992, 22(4):911-922.
6. Burgut F.T., Benaur M., Hencliffe C. Late-life depression: a neuropsychiatric approach. Expert Rev Neurother 2006, 6(1):65-72.
7. Ballard C., Holmes C., McKeith I., et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999, 156(7):1039-1045.
8. American Psychiatric Association. Task force on electroconvulsive therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. Washington, DC: American Psychiatric Association; 2001.
9. Wilkins K.M., Ostroff R., Tampi R.R. Efficacy of electroconvulsive therapy in the treatment of non depressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol 2008, 21(1):3-11.
10. Rao V., Lyketsos C.G. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry 2000, 15(8):729-735.
11. Keith Rasmussen M.D., Calvin Russell P.A.-C., Simon Kung M.D., et al. Electroconvulsive therapy for patients with major depression and probable Lewy body dementia. J ECT 2003, 19(2):103-109.
12. Sho Takahashi, Katsuyoshi Mizukami, Fumihiko Yasuno, et al. Depression with dementia with Lewy bodies and the effect of somatotherapy. Psychogeriatrics 2009, 9:56-61.
13. Emre M., Aarsland D., Brown R., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007, 22(!2):1689-1707.
14. McKeith I.G., Galasko D., Kosaka K. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47(5):1113-1124.
15. Rasmussen K., Abrams R. Treatment of Parkinson's disease with electroconvulsive therapy. Psychiatr Clin North Am 1991, 14(4):925-933.
16. Popeo D., Kellner C.H. ECT for Parkinson's disease. Med Hypotheses 2009, 73(4):468-469.
17. Aarsland D., Ballard C., Larsen J.P., et al. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001, 16(5):528-536.
18. Aarsland D., Perry R., Larsen J.P. Neuroleptic sensitivity in Parkinson's disease and Parkinsonian dementias. J Clin Psychiatry 2005, 66(5):633-637.
19. Douyon R., Serby M., Klutchko B., Rotrosen J. ECT and Parkinson's disease revisited: a " naturalistic" study. Am J Psychiatry 1989, 146(11):1451-1455.
20. Hurwitz T.A., Calne D.B., Waterman K. Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy. Can J Neurol Sci 1988, 15(1):32-34.
21. Ueda S., Koyama K., Okubo Y. Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease. J ECT 2010.
22. Rasimas J.J. Treatment of psychosis in Lewy body disease. Am J Psychiatry 2008, 165(2):261.